GNLX Stock Price
GNLX
GNLX stock price is $1.96 (+7.69% on the day), giving GNLX a market cap of $82.35M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
GNLX Stock Overview
- Price
- $1.96
- Previous close
- $1.82
- Open
- $1.83
- Market cap
- $82.35M
- 1-year price target
- $18.83
- MarketXLS Rank
- 28
About GNLX
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GNLX | $1.96 | +7.7% | 323.35K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |